acid-phosphatase and aristolic-acid

Aristolic acid (AA), obtained from Aristolochia indica Linn, disrupted nidation in mice when administered on Day 1 of pregnancy. The implantation inhibiting effect of the compound was assessed with respect to certain parameters which are characteristics of early pregnancy, such as tubal transport of ova into the uterus, hyperpermeability of the endometrial capillaries, increase in uterine weight and total protein content, endometrial bed preparation and changes in uterine phosphatase enzymes during Days 4-6 of pregnancy. The compound did not affect tubal transport of eggs, but the uterine blue reaction, caused by extravasation of the dye, pontamine blue, at future implantation sites was inhibited significantly in treated mice. Histological picture of the uterus revealed AA-induced impairment of development (i.e. decidualization) and reconciled with decreases found in uterine weight and its total protein contents in treated animals. In control untreated mice, specific uterine alkaline phosphatase (ALP) activity increased significantly from Days 4 through 6 of pregnancy, but this was prevented in treated mice. On the other hand, specific uterine acid phosphatase (AP) activity was high on Day 5, while in treated mice uterine AP activity remained low during Days 4 and 5 and increased significantly thereafter. It was inferred that AA interferes with steroidal conditioning of the uterus and renders it hostile to ovum implantation.

Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Aristolochic Acids; Embryo Implantation; Female; Histocytochemistry; Mice; Mice, Inbred Strains; Phenanthrenes; Plant Extracts; Pregnancy; Uterus

Aristolic acid (AA) exerted interceptive activity in mice. A single oral dose of aristolic acid at the dose levels of 120 and 90 mg/kg on Day 1 or Day 6 of pregnancy in mouse resulted in a rise of acid phosphatase (AP) and fall of alkaline phosphatase (ALP) and protein in uterus in both groups. Both delta 5-3 beta-hydroxy-steroid dehydrogenase (delta 5-3 beta-HSD) and glucose 6-phosphate-dehydrogenase (G6PD) of ovaries remained unaltered. Exogenous progesterone (1 mg s.c., Days 5-8) administered along with aristolic acid (on Day 6 only) could neither protect pregnancy nor prevent the biochemical changes produced in the uterus due to drug treatment. This unaltered steroidogenesis and alteration in alkaline phosphatase, acid phosphatase and protein gives some insight into the mechanism of action of the compound aristolic acid.

Topics: Abortifacient Agents; Acid Phosphatase; Administration, Oral; Alkaline Phosphatase; Animals; Aristolochic Acids; Decidua; Embryo Implantation; Embryonic Development; Female; Mice; Mice, Inbred Strains; Phenanthrenes; Plant Extracts; Pregnancy; Pregnancy Proteins